Emergence of NDM-1 and OXA-72 producing Acinetobacter pittii clinical isolates in Lebanon

A Al Atrouni1, M-L Joly-Guillou2, M Hamze3

  • 1Laboratoire Microbiologie Santé et Environnement (LMSE), Ecole Doctorale des Sciences et de Technologie et Faculté de Santé Publique, Université Libanaise, Tripoli, Liban; ATOMycA, Inserm Atip-Avenir Team, CRCNA, Inserm U892, 6299 CNRS, University of Angers, France.

Insights

The first detection of carbapenem-resistant Acinetobacter pittii in Lebanon is reported. These clinical isolates carry concerning resistance genes, bla NDM-1 or bla OXA-72.

Area of Science:

  • Microbiology
  • Infectious Diseases
  • Antimicrobial Resistance

Background:

  • Acinetobacter species are significant opportunistic pathogens causing diverse infections globally.
  • The rise of carbapenem resistance in Acinetobacter poses a major public health threat.

Observation:

  • This study reports the initial identification of Acinetobacter pittii clinical isolates in Lebanon.
  • These isolates were found to harbor specific carbapenemase genes.

Findings:

  • The detected carbapenem resistance genes include bla NDM-1 and bla OXA-72.
  • This marks the first documented occurrence of these resistance mechanisms in Acinetobacter pittii within Lebanon.

Implications:

  • Highlights the urgent need for enhanced surveillance of carbapenem-resistant Acinetobacter in the region.
  • Informs antimicrobial stewardship and infection control strategies against emerging multidrug-resistant pathogens.

Related Concept Videos

Clinical Significance of Antibiotic Resistance01:25

Clinical Significance of Antibiotic Resistance

Methicillin-resistant Staphylococcus aureus (MRSA) presents a critical public health threat, arising from its capacity to resist β-lactam antibiotics due to acquisition of the mecA gene within the staphylococcal cassette chromosome mec (SCCmec). This gene encodes penicillin-binding protein 2a (PBP2a), which impairs binding efficacy of methicillin and other β-lactams. MRSA has evolved into distinct clonal lineages impacting humans and animals alike, reinforcing its significance within...
7
Mechanism of Antibiotic Resistance in MRSA01:25

Mechanism of Antibiotic Resistance in MRSA

Antibiotic resistance in bacteria arises when microorganisms evolve the ability to withstand drugs designed to kill them or inhibit their growth, rendering once-effective treatments useless. This phenomenon, driven by genetic change and selection under antibiotic exposure, poses a profound threat to modern medicine. Mechanisms include drug-inactivating enzymes (e.g., β-lactamases), efflux pumps that eject antibiotics, mutations altering antibiotic targets, decreased drug uptake, and...
37
Atypical Pneumonia01:14

Atypical Pneumonia

Atypical pneumonia, often caused by Mycoplasma pneumoniae, is a form of pulmonary infection that differs from the classical presentation of bacterial pneumonia in both its cause and clinical symptoms. Mycoplasma pneumoniae is a pleomorphic bacterium notable for its lack of a rigid cell wall. This structural characteristic imparts resistance to beta-lactam antibiotics and significantly influences the bacterium’s behavior within the human host.Other pathogens responsible for the disease...
9
Development of Antibiotic Resistance01:30

Development of Antibiotic Resistance

Antibiotic resistance is a major public health concern that arises when bacteria evolve mechanisms to withstand the effects of antibiotic treatments. This resistance can be intrinsic, acquired through genetic mutations, or transferred between bacteria via horizontal gene transfer. The development of antibiotic resistance poses significant challenges in treating bacterial infections and necessitates ongoing research to develop new therapeutic strategies.Intrinsic resistance occurs when bacterial...
1.9K